Related Experiment Video
Updated: May 29, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Rhabdomyolysis caused by an interaction of simvastatin and fusidic acid
Roselle Herring1, Gordon Caldwell, Stuart Wade
1Worthing and Southlands NHS Trust, Endocrine and Diabetes, Worthing Hospital, Lyndhurst Road, West Sussex, BN11 2DH, UK.
Abstract:
A case of severe rhabdomyolysis caused by an interaction between fusidic acid and simvastatin is described. Fusidic acid significantly reduces the excretion of simvastatin resulting in increased plasma levels thereby increasing the side effect profile. Simvastatin treatment should be temporarily withheld during treatment with fusidic acid.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmacokinetics: Drug–Drug Interactions
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug toxicity: Idiosyncratic Reactions